RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer
Abstract Background The aim of this study was to explore the associations of RIPK1 polymorphisms, plasma levels and mRNA expression with susceptibility to epithelial ovarian cancer (EOC) and clinical outcome. Methods Three hundred and nineteen EOC patients included in a 60-month follow-up program an...
Main Authors: | Xuedong Wang, Kui Deng, Jing Tao, Juan Zou, Yiting Du, Li Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-11-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-023-03139-7 |
Similar Items
-
RIPK4 Promotes Cell Invasion and the Epithelial–Mesenchymal Transition in Ovarian Cancer
by: Li Hua, et al.
Published: (2023-12-01) -
High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer
by: Liwei Zhang, et al.
Published: (2022-02-01) -
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
by: Sipei Nie, et al.
Published: (2021-09-01) -
FBXO22 Promotes Growth and Metastasis and Inhibits Autophagy in Epithelial Ovarian Cancers via the MAPK/ERK Pathway
by: Minle Li, et al.
Published: (2021-12-01) -
The Molecular Landscape Influencing Prognoses of Epithelial Ovarian Cancer
by: Chao-Lien Liu, et al.
Published: (2021-07-01)